Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (Q24246631)

chronic inflammatory demyelinating polyradiculoneuropathy

Europe PubMed Central

title

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (English)

0 references

main subject

0 references

inflammation

0 references

author name string

Man Mohan Mehndiratta

series ordinal

1

0 references

Richard AC Hughes

series ordinal

2

0 references

Puneet Agarwal

series ordinal

3

0 references

publication date

19 July 2004

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

Clinical spectrum of chronic acquired demyelinating polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Complications of therapeutic plasma exchange: a recent assessment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Current treatments of chronic immune-mediated demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Peripheral neuropathy in osteosclerotic myeloma: Clinical and electrodiagnostic improvement with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Impact of plasma exchange on indices of demyelination in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Chronic relapsing polyneuritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Treating chronic relapsing Guillain-Barré syndrome by plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Treatment of chronic relapsing Guillain-Barré syndrome by plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Multifocal motor neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Recurrent and chronic relapsing Guillain-Barré polyneuritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Plasma exchange in immune-mediated neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Treatment of Guillain-Barré syndrome and CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Specificity of plasmapheresis in the treatment of chronic relapsing polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

"Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Immunoadsorption inferior to plasma exchange in a patient with chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy; different beneficial effects and their correlation to the clinical features

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021

Immunosuppressive agents and plasmapheresis in immunological disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003906.PUB2

7 January 2021